Kansere Karşı Stand Up, Kanser Ölümünün Dünyanın Üçüncü Önde Gelen Nedeni Mide Kanserinin Erken Teşhisi Konusunda Uluslararası Ekibi Duyurdu

SANTA MONICA, CA. – 27 Ocak 2020 – Kansere Karşı Ayakta (SU2C) bugün uluslararası bir uzman ekibinin dünyanın üçüncü önde gelen kanser ölüm nedeni – mide (veya mide) kanseri ile mücadelede yeni bir yaklaşım benimseyeceğini duyurdu.

Phillip A, “Çok sık olarak, mide kanseri, tedavisi çok zor olduğunda, ileri bir aşamada tespit edilir” dedi. Sharp, PhD, Institute professor, David H. Koch Institute for Integrative Cancer Research at MIT, the Nobel Laureate who serves as chair of SU2C’s Scientific Advisory Committee. QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

Andrew T. Chan, MD, MPH, Harvard Tıp Fakültesi’nde tıp profesörü ve Massachusetts Genel Hastanesi Kanser Merkezi’nde kanser epidemiyolojisi direktörü, SU2C Mide Kanseri Önleme Araştırma Ekibinin lideri olarak görev yapacak. Yardımcı lider, Pennsylvania Üniversitesi Perelman Tıp Fakültesi’nde kanser biyolojisi doçenti olan Sandra Ryeom. Ekipte Chicago Üniversitesi, Umut Şehri Kapsamlı Kanser Merkezi, Memorial Sloan Kettering Kanser Merkezi ve Samsung Tıp Merkezi’nden araştırmacılar yer alıyor.

Araştırma ekibi, kan sisteminde dolaşan ve mide kanserinin varlığını gösteren tümörden dökülen belirli DNA parçaları ve hücreler gibi biyobelirteçleri belirlemek için yoğun çalışmalar yürütecek.

Marty Cless,

“Mide kanseri yıkıcı bir teşhis olabilir çünkü çok kötü bir prognoz taşıyor” dedi. “Babamın bu hastalıkla savaşını kaybettiğine tanık olduktan sonra, aciliyet erken teşhis. Bu kanserleri daha erken bulmak için yeni tanı araçları geliştirmek, hasta sonuçlarını iyileştirecek ve prognozu korkunçtan umutluya değiştirecektir.”

Jeff Schottenstein,” SU2C ve Cless ailesiyle işbirliği içinde mide kanseri hastalarına erken müdahale getirmek, mide hastalarının bu yıkıcı hastalığa karşı zafer kazanmasına yardımcı olmanın anahtarıdır ” dedi. “Bu proje, 2016 ‘da mide kanseriyle mücadelesini kaybeden ilham verici, nazik ve güzel eşim Sara Schottenstein’ın anısını onurlandırıyor. Sara çok sıcak ve sevgi dolu bir insandı. Mirasının başkalarına bu kadar anlamlı bir şekilde yardım etmeyi içerdiğini bilmek beni derinden etkiledi.”

Dünya Kanser Araştırma Fonu’na (WCRF) göre, ABD merkezli bilim insanlarına ek olarak, ekip, dünyanın en yüksek mide kanseri oranına sahip ülkesi olan Güney Kore’nin Seul kentindeki Samsung Tıp Merkezi’ndeki araştırmacıları da içeriyor.

Stomach cancer – also known as gastric cancer – is the fifth most common cancer worldwide, and third-leading cause of cancer death, according to the WCRF. Around 952,000 new cases of stomach cancer occurred around the world in 2012, accounting for seven percent of all new cases of cancer. About 70 percent of cases of stomach cancer occur in less developed countries with about half of all cases in Eastern Asia, particularly China.

In the United States, the rate of survival five years after diagnosis is only 32 percent, according to the National Cancer Institute. Survival rates are lower in less-developed countries, according to the WCRF. The poor prognosis is attributed largely to the fact that symptoms often appear only at a late stage in the development of the cancer.

“We have been actively involved in developing new endoscopic imaging techniques that can define areas of the stomach that are at high risk of developing cancer,” Chan said. “We can also use this information to derive new blood-based biomarkers that can be used for early detection of stomach cancer.”

Techniques to be explored include a tiny, pill-sized camera that can be swallowed by a patient without sedation, Chan said. QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS Teams established earlier focus on cancers of the lung and pancreas and on multiple myeloma, a malignancy of the bone marrow.

Key team members include:

Andrew T. QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS SU2C, a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization, was established in 2008 by media and entertainment leaders who utilize these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of December 2019, more than 1,600 scientists representing more than 180 institutions are involved in SU2C-funded research projects.

Under the direction of our Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, PhD, SU2C operates rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and ensure collaboration across research programs.

Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Sung Poblete, PhD, RN, serves as SU2C’s CEO. For more information, visit StandUpToCancer.org.

About The Cless Family Foundation
The Cless Family Foundation was formed in 1991 by Ruth and Gerhard Cless. Since its inception, the foundation’s focus has been dedicated to improving and supporting education in the sciences, technology, and engineering. The foundation’s support has evolved to include promising advancements in the medical field as our family, like many others, has faced life threatening illnesses and want to do whatever we can to improve future outcomes. Today, Gerhard’s legacy is carried on by the Cless children and grandchildren who were taught to live by the golden rule, support causes you believe in and help those under served.

About the Sara and Jeff Schottenstein Foundation
The Sara and Jeff Schottenstein Fund honors Sara Schottenstein who lost her brave battle against gastric cancer in 2016 by supporting cancer patients and cancer research, particularly championing gastric cancer research. Sara was kind, warm, and beautiful, and deeply loved and respected by her family, friends and community. Her legacy lives on through her three adoring children as well as the critical work of this Fund.

Media Contact:
Jane E. Rubinstein
Sr. VP Communications
646-386-7969 ofc / 516-993-0708 cell
jrubinstein@su2c.org